COMMUNIQUÉS West-GlobeNewswire

Momenta Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update
07/11/2018
CAMBRIDGE, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA) today reported its financial results for the third quarter ended September 30, 2018 and provided a corporate update. “We [...]
Achillion Reports Third Quarter 2018 Financial Results
07/11/2018
- Completed enrollment of Phase 2 clinical trial of ACH-4471 in PNH as monotherapy - - Interim data and strategic update planned for December 17, 2018 – - September 30, 2018 cash & securities position of $283 [...]
Tetraphase Pharmaceuticals to Present at Upcoming Investor Conferences
07/11/2018
WATERTOWN, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening [...]
Immunicum AB (publ) Interim Report July - September 2018
07/11/2018
Press Release 7 November 2018 Immunicum AB (publ) Interim Report July - September 2018 Positive preclinical results presented at ESMO Significant Events During the Third Quarter Immunicum announced protocol approval by [...]
Rule 2.9 Announcement
07/11/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 7 November 2018 [...]
Sensorion Announces Presentation of SENS-401 Poster at Society for Neuroscience 2018 Annual Meeting
07/11/2018
Preclinical data suggest efficacy of SENS-401 is not affected by concomitant administration of a corticosteroid Adds to evidence supporting use of SENS-401 in sudden sensorineural hearing loss (SSNHL) Phase II trial of [...]
Lundbeck realized 12% growth in revenue (local currencies) and 56% growth in EPS in 9M 2018. Guidance for FY2018 raised
07/11/2018
Valby, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Financial report for the period 1 January to 30 September 2018 Lundbeck realized 12% growth in revenue (local currencies) and 56% growth in EPS in 9M 2018. Guidance for FY2018 [...]
MDxHealth (R): SelectMDx improves prostate biopsy decision-making in urology practices
07/11/2018
NEWS RELEASE REGULATED INFORMATION Real-world study shows that SelectMDx helps urologists more confidently determine the need for an initial prostate biopsy IRVINE, CA, and HERSTAL, BELGIUM - 07.00 CEST, 7 November 2018 [...]
MDxHealth (R): SelectMDx améliore la prise de décision en matière de biopsie de la prostate dans les cabinets d'urologie
07/11/2018
COMMUNIQUÉ DE PRESSE INFORMATIONS RÉGLEMENTÉES Une enquête menée en situation réelle prouve que le test SelectMDx aide les urologues à mieux établir le besoin de procéder ou non à une biopsie de la prostate initiale [...]
ObsEva SA to Participate in November Investor Conferences
07/11/2018
Geneva, Switzerland and Boston, MA – November 7, 2018 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]
Esperite Group with The Cell Factory, expands its patent portfolio on extra-cellular vesicles biologic drugs in Canada.
07/11/2018
Amsterdam, the Netherlands - 7 November 2018 Esperite's (Euronext: ESP) biotech company The Cell Factory has obtained the patent for the use of extracellular vesicles (EVs) in the treatment of acute and chronic [...]
Bone Therapeutics Business Update for Third Quarter 2018
07/11/2018
Regulated information Positive efficacy and safety results in ALLOB Delayed Union Phase I/II trial, supporting next stage in clinical development Manufacturing process optimisation implemented for allogeneic platform [...]
Bone Therapeutics publie son rapport d’activité du troisième trimestre 2018
07/11/2018
Information réglementée Résultats positifs d’efficacité et de sécurité de l’étude de Phase I/II avec ALLOB dans les fractures avec retard de consolidation, encourageant la poursuite du développement clinique Mise en [...]
XORTX Announces Appointment of CFO
07/11/2018
CALGARY, Alberta, Nov. 06, 2018 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE:XRX; OTCQB:XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat [...]
Aeterna Zentaris Reports Third Quarter 2018 Financial and Operating Results
07/11/2018
CHARLESTON, S.C., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS), a biopharmaceutical company engaged in developing and commercializing pharmaceutical products, today reported [...]
Oxford Immunotec Schedules Third Quarter 2018 Earnings Release and Business Update Conference Call for November 9, 2018
06/11/2018
OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD), a global, high-growth diagnostics company, today announced that it plans to release third [...]
Akorn Provides Third Quarter 2018 Results
06/11/2018
LAKE FOREST, Ill., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced its financial results for the third quarter of 2018. Business [...]
National Research Corporation Announces Third Quarter 2018 Results
06/11/2018
LINCOLN, Neb., Nov. 06, 2018 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ:NRC) today announced results for the third quarter of 2018. Net New Sales of $6.2 million Revenue up 4% to $30 million Operating [...]
Mersana Therapeutics to Host Conference Call Announcing Third Quarter 2018 Financial Results and Business Updates
06/11/2018
CAMBRIDGE, Mass., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs [...]

Pages